2023 Q3 Form 10-Q Financial Statement

#000117184323004473 Filed on July 13, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2022 Q2
Revenue $20.71M $20.97M $18.96M
YoY Change 2.26% 10.57% 23.0%
Cost Of Revenue $13.35M $13.28M $12.72M
YoY Change -5.4% 4.38% 25.32%
Gross Profit $7.360M $7.689M $6.242M
YoY Change 19.88% 23.18% 18.54%
Gross Profit Margin 35.54% 36.67% 32.91%
Selling, General & Admin $8.440M $6.874M $6.011M
YoY Change 29.12% 14.36% 14.63%
% of Gross Profit 114.67% 89.4% 96.29%
Research & Development $1.570M $1.151M $1.103M
YoY Change 59.39% 4.33% 3.42%
% of Gross Profit 21.33% 14.97% 17.67%
Depreciation & Amortization $420.0K $424.0K $449.9K
YoY Change 12.97% -5.77% 58.88%
% of Gross Profit 5.71% 5.51% 7.21%
Operating Expenses $8.620M $6.663M $7.114M
YoY Change 54.21% -6.33% 12.73%
Operating Profit -$1.260M $1.026M $1.823M
YoY Change -329.27% -43.72% -29.31%
Interest Expense $2.680M $1.219M $23.78K
YoY Change 162.44% 5026.85% 681.34%
% of Operating Profit 118.85% 1.3%
Other Income/Expense, Net
YoY Change
Pretax Income $1.420M $2.245M $1.815M
YoY Change -9.6% 23.7% -29.82%
Income Tax $510.0K $542.3K $604.3K
% Of Pretax Income 35.92% 24.15% 33.29%
Net Earnings $0.00 $1.526M $1.000M
YoY Change -100.0% 52.53% -51.3%
Net Earnings / Revenue 0.0% 7.28% 5.27%
Basic Earnings Per Share $0.16 $0.11
Diluted Earnings Per Share $0.00 $0.16 $0.11
COMMON SHARES
Basic Shares Outstanding 9.370M 9.366M 9.228M
Diluted Shares Outstanding 9.628M 9.579M

Balance Sheet

Concept 2023 Q3 2023 Q2 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.406M $6.195M $6.129M
YoY Change 1.25% 1.08% -44.31%
Cash & Equivalents $5.406M $6.195M $6.123M
Short-Term Investments $0.00 $0.00 $5.574K
Other Short-Term Assets $2.020M $1.832M $2.619M
YoY Change 3.39% -30.07% 153.06%
Inventory $13.10M $13.90M $13.87M
Prepaid Expenses $2.019M $1.832M $2.619M
Receivables $15.83M $15.98M $14.69M
Other Receivables $3.320M $1.382M $1.662M
Total Short-Term Assets $39.67M $39.29M $38.97M
YoY Change -1.4% 0.83% 4.67%
LONG-TERM ASSETS
Property, Plant & Equipment $14.07M $14.10M $12.07M
YoY Change 15.57% 16.84% 68.19%
Goodwill $4.782M $4.782M $4.782M
YoY Change 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments $23.71M $22.86M $22.19M
YoY Change 8.67% 2.98% -17.61%
Other Assets $530.0K $421.6K
YoY Change -13.4%
Total Long-Term Assets $49.67M $48.02M $46.22M
YoY Change 8.08% 3.91% 29.93%
TOTAL ASSETS
Total Short-Term Assets $39.67M $39.29M $38.97M
Total Long-Term Assets $49.67M $48.02M $46.22M
Total Assets $89.34M $87.31M $85.19M
YoY Change 3.65% 2.5% 17.01%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.056M $4.688M $6.005M
YoY Change -22.32% -21.94% 46.32%
Accrued Expenses $4.290M $2.850M $3.437M
YoY Change 28.51% -17.06% 4.7%
Deferred Revenue
YoY Change
Short-Term Debt $6.360M $8.012M $4.700M
YoY Change 7.8% 70.48%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $16.72M $15.55M $14.24M
YoY Change -2.02% 9.19% 88.56%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $90.00K $213.0K $347.3K
YoY Change -51.15% -38.68% -6.94%
Total Long-Term Liabilities $1.924M $213.0K $2.268M
YoY Change 2.12% -90.61% 507.84%
TOTAL LIABILITIES
Total Short-Term Liabilities $16.72M $15.55M $14.24M
Total Long-Term Liabilities $1.924M $213.0K $2.268M
Total Liabilities $18.65M $20.92M $16.51M
YoY Change -1.61% 26.69% 108.3%
SHAREHOLDERS EQUITY
Retained Earnings $51.00M $51.66M $50.71M
YoY Change 0.57% 1.87% 10.45%
Common Stock $22.18M $21.61M $19.89M
YoY Change 10.19% 8.66% 9.44%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $66.36M $66.40M $65.22M
YoY Change
Total Liabilities & Shareholders Equity $89.34M $87.31M $85.19M
YoY Change 3.65% 2.5% 17.01%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2022 Q2
OPERATING ACTIVITIES
Net Income $0.00 $1.526M $1.000M
YoY Change -100.0% 52.53% -51.3%
Depreciation, Depletion And Amortization $420.0K $424.0K $449.9K
YoY Change 12.97% -5.77% 58.88%
Cash From Operating Activities $2.030M $1.301M -$340.6K
YoY Change -421.2% -481.92% -62.41%
INVESTING ACTIVITIES
Capital Expenditures $660.0K $755.4K -$395.9K
YoY Change -214.36% -290.82% 41.66%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 -$342.3K
YoY Change -100.0% -100.0% -143.35%
Cash From Investing Activities -$660.0K -$755.4K -$738.2K
YoY Change 14.36% 2.33% -244.68%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -2.130M 193.4K -151.7K
YoY Change -484.66% -227.46% -72.39%
NET CHANGE
Cash From Operating Activities 2.030M 1.301M -340.6K
Cash From Investing Activities -660.0K -755.4K -738.2K
Cash From Financing Activities -2.130M 193.4K -151.7K
Net Change In Cash -760.0K 738.9K -1.231M
YoY Change 15.96% -160.05% 30.12%
FREE CASH FLOW
Cash From Operating Activities $2.030M $1.301M -$340.6K
Capital Expenditures $660.0K $755.4K -$395.9K
Free Cash Flow $1.370M $545.6K $55.23K
YoY Change -2595.9% 887.8% -108.81%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q2 ntic Trade Receivables Joint Ventures Current
TradeReceivablesJointVenturesCurrent
668847 usd
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
293137 usd
CY2023Q2 us-gaap Assets
Assets
87313423 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
4687675 usd
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000
us-gaap Selling Expense
SellingExpense
10649316 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2560487 usd
CY2023Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1346658 usd
CY2023Q2 ntic Fees For Services Provided To Joint Ventures
FeesForServicesProvidedToJointVentures
1361311 usd
CY2023Q2 ntic Income From Joint Venture Operations
IncomeFromJointVentureOperations
2707969 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3150643 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
8024519 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
2372592 usd
dei Entity Central Index Key
EntityCentralIndexKey
0000875582
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--08-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 pure
us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
0
us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
0
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q3 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0
CY2023Q2 us-gaap Preferred Stock No Par Value
PreferredStockNoParValue
0
CY2023Q2 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
0 usd
CY2022Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
5590 usd
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
439000 usd
CY2022Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
439000 usd
CY2023Q2 ntic Trade Receivables Excluding Joint Ventures Net Current
TradeReceivablesExcludingJointVenturesNetCurrent
15311650 usd
CY2022Q3 ntic Trade Receivables Excluding Joint Ventures Net Current
TradeReceivablesExcludingJointVenturesNetCurrent
14136930 usd
CY2022Q3 ntic Trade Receivables Joint Ventures Current
TradeReceivablesJointVenturesCurrent
697861 usd
CY2023Q2 ntic Fees Receivable For Services Provided To Joint Ventures Current
FeesReceivableForServicesProvidedToJointVenturesCurrent
1226010 usd
CY2022Q3 ntic Fees Receivable For Services Provided To Joint Ventures Current
FeesReceivableForServicesProvidedToJointVenturesCurrent
1765117 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
6281625 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
6633878 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
557571 usd
CY2023Q2 ntic Assets Noncurrent Other Than Property Plant And Equipment
AssetsNoncurrentOtherThanPropertyPlantAndEquipment
34212586 usd
CY2022Q3 ntic Assets Noncurrent Other Than Property Plant And Equipment
AssetsNoncurrentOtherThanPropertyPlantAndEquipment
33788579 usd
CY2022Q3 us-gaap Assets
Assets
86193953 usd
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
7796494 usd
CY2023Q2 us-gaap Secured Debt Current
SecuredDebtCurrent
2812504 usd
CY2022Q3 us-gaap Secured Debt Current
SecuredDebtCurrent
0 usd
CY2023Q2 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
5200000 usd
CY2022Q3 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
5900000 usd
CY2023Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
0 usd
CY2022Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
30742 usd
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2035785 usd
CY2022Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2297543 usd
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
734414 usd
CY2022Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
667292 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
80183 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
373330 usd
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
15550561 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
17065401 usd
CY2023Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1618960 usd
CY2022Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1700015 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
212954 usd
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
184241 usd
CY2023Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1831914 usd
CY2022Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1884256 usd
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000
CY2023Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.02
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.02
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
15000000
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
15000000
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9369923
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9369923
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9232483
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9232483
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
187398 usd
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
184650 usd
CY2023Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
21426721 usd
CY2022Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
19939131 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
51662515 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
50716613 usd
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-6879447 usd
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-7245132 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
66397187 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
63595262 usd
CY2023Q2 us-gaap Minority Interest
MinorityInterest
3533761 usd
CY2022Q3 us-gaap Minority Interest
MinorityInterest
3649034 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
69930948 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
67244296 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
87313423 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
86193953 usd
CY2023Q2 us-gaap Revenues
Revenues
20969726 usd
CY2022Q2 us-gaap Revenues
Revenues
18964921 usd
us-gaap Revenues
Revenues
59193317 usd
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
13280584 usd
CY2022Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
12722833 usd
us-gaap Gross Profit
GrossProfit
20445452 usd
CY2022Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1364597 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
3664793 usd
CY2022Q2 ntic Fees For Services Provided To Joint Ventures
FeesForServicesProvidedToJointVentures
1329988 usd
ntic Fees For Services Provided To Joint Ventures
FeesForServicesProvidedToJointVentures
3795862 usd
CY2022Q2 us-gaap Selling Expense
SellingExpense
3450308 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3401885 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
7113737 usd
us-gaap Operating Expenses
OperatingExpenses
23416632 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
1822936 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
4489475 usd
CY2023Q2 us-gaap Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain Or Loss
BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss
0 usd
CY2022Q2 us-gaap Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain Or Loss
BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss
0 usd
us-gaap Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain Or Loss
BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss
0 usd
us-gaap Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain Or Loss
BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss
3951550 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
331303 usd
CY2022Q2 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
100000 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
1210763 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1554022 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
68675670 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
67244296 usd
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
75464 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
416563 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
998311 usd
us-gaap Dividends
Dividends
1967184 usd
us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
555574 usd
us-gaap Profit Loss
ProfitLoss
3330504 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
388568 usd
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
65750581 usd
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
73645 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
198640 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation And Exercise Of Stock Options
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions
698649 usd
us-gaap Dividends
Dividends
1934906 usd
us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
402729 usd
us-gaap Profit Loss
ProfitLoss
6228581 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1936791 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
68675670 usd
us-gaap Profit Loss
ProfitLoss
3330504 usd
us-gaap Profit Loss
ProfitLoss
6228581 usd
us-gaap Share Based Compensation
ShareBasedCompensation
998311 usd
us-gaap Share Based Compensation
ShareBasedCompensation
698649 usd
us-gaap Depreciation
Depreciation
766091 usd
us-gaap Depreciation
Depreciation
722443 usd
us-gaap Adjustment For Amortization
AdjustmentForAmortization
441603 usd
us-gaap Adjustment For Amortization
AdjustmentForAmortization
474121 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
8534 usd
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-0 usd
us-gaap Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain Or Loss
BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss
-0 usd
us-gaap Business Combination Step Acquisition Equity Interest In Acquiree Remeasurement Gain Or Loss
BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementGainOrLoss
3951550 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
3664793 usd
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
3662178 usd
us-gaap Proceeds From Dividends Received
ProceedsFromDividendsReceived
3510716 usd
us-gaap Proceeds From Dividends Received
ProceedsFromDividendsReceived
5723176 usd
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
76114 usd
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-152372 usd
ntic Increase Decrease In Trade Receivables Excluding Joint Ventures
IncreaseDecreaseInTradeReceivablesExcludingJointVentures
1502567 usd
ntic Increase Decrease In Trade Receivables Excluding Joint Ventures
IncreaseDecreaseInTradeReceivablesExcludingJointVentures
1348254 usd
ntic Increase Decrease In Trade Receivables Joint Ventures
IncreaseDecreaseInTradeReceivablesJointVentures
-29014 usd
ntic Increase Decrease In Trade Receivables Joint Ventures
IncreaseDecreaseInTradeReceivablesJointVentures
232364 usd
ntic Increase Decrease In Fees Receivable For Services Provided To Joint Ventures
IncreaseDecreaseInFeesReceivableForServicesProvidedToJointVentures
-539107 usd
ntic Increase Decrease In Fees Receivable For Services Provided To Joint Ventures
IncreaseDecreaseInFeesReceivableForServicesProvidedToJointVentures
-261913 usd
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
155828 usd
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
134942 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-2254758 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2093668 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-184516 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
635478 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-2902121 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
908605 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-29401 usd
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-420529 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-209459 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-912803 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3505803 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1778094 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
-0 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
5062003 usd
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
-0 usd
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
941 usd
ntic Proceeds From Sale Payments To Acquire Debt Securities Availableforsale
ProceedsFromSalePaymentsToAcquireDebtSecuritiesAvailableforsale
5590 usd
ntic Proceeds From Sale Payments To Acquire Debt Securities Availableforsale
ProceedsFromSalePaymentsToAcquireDebtSecuritiesAvailableforsale
0 usd
us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
-0 usd
us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
341392 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2607988 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
961704 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
13000 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
89350 usd
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
164994 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2678748 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6531034 usd
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
555574 usd
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
402729 usd
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
700000 usd
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
-0 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
4700000 usd
us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
2812504 usd
us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
0 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
1967184 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
1934906 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
416563 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
198640 usd
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
75464 usd
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
73645 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
81773 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2634650 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-47524 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
560918 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
861304 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1557372 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
5333890 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
7680641 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
6195194 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
6123269 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
9662005 usd
CY2023Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
4723520 usd
CY2022Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
6496656 usd
CY2023Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
9177292 usd
CY2022Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
9845073 usd
CY2023Q2 us-gaap Inventory Net
InventoryNet
13900812 usd
CY2022Q3 us-gaap Inventory Net
InventoryNet
16341729 usd
CY2023Q2 us-gaap Land
Land
496965 usd
CY2022Q3 us-gaap Land
Land
310365 usd
CY2023Q2 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
16733247 usd
CY2022Q3 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
14778759 usd
CY2023Q2 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
5960024 usd
CY2022Q3 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
5643320 usd
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
23190236 usd
CY2022Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
20732444 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
9379306 usd
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
8561951 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13810930 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12170493 usd
CY2023Q2 us-gaap Depreciation
Depreciation
277253 usd
us-gaap Depreciation
Depreciation
766091 usd
CY2022Q2 us-gaap Depreciation
Depreciation
291452 usd
us-gaap Depreciation
Depreciation
722443 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3380380 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
6281625 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
9572655 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2938777 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
6633878 usd
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
146730 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
441603 usd
CY2022Q2 us-gaap Dividends Payable Date Of Record Day Month And Year
DividendsPayableDateOfRecordDayMonthAndYear
2022-05-04
CY2022Q2 us-gaap Dividend Payable Date To Be Paid Day Month And Year
DividendPayableDateToBePaidDayMonthAndYear
2022-05-18
CY2022Q3 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
3620
CY2021Q3 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
2636
CY2023Q1 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
3566
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
158490 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
474121 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
167471 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
589746 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
589746 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
589746 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
589746 usd
CY2023Q2 ntic Finite Lived Intangible Asset Expected Amortization After Year Four
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
3755170 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
6281625 usd
CY2022Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.07
CY2022Q4 us-gaap Dividends Payable Date Of Record Day Month And Year
DividendsPayableDateOfRecordDayMonthAndYear
2022-11-03
CY2022Q4 us-gaap Dividend Payable Date To Be Paid Day Month And Year
DividendPayableDateToBePaidDayMonthAndYear
2022-11-16
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.07
CY2023Q1 us-gaap Dividends Payable Date Of Record Day Month And Year
DividendsPayableDateOfRecordDayMonthAndYear
2023-02-01
CY2023Q1 us-gaap Dividend Payable Date To Be Paid Day Month And Year
DividendPayableDateToBePaidDayMonthAndYear
2023-02-15
CY2023Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.07
CY2023Q2 us-gaap Dividends Payable Date Of Record Day Month And Year
DividendsPayableDateOfRecordDayMonthAndYear
2023-05-03
CY2023Q2 us-gaap Dividend Payable Date To Be Paid Day Month And Year
DividendPayableDateToBePaidDayMonthAndYear
2023-05-17
CY2021Q4 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.07
CY2021Q4 us-gaap Dividends Payable Date Of Record Day Month And Year
DividendsPayableDateOfRecordDayMonthAndYear
2021-11-03
CY2021Q4 us-gaap Dividend Payable Date To Be Paid Day Month And Year
DividendPayableDateToBePaidDayMonthAndYear
2021-11-17
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.07
CY2022Q1 us-gaap Dividends Payable Date Of Record Day Month And Year
DividendsPayableDateOfRecordDayMonthAndYear
2022-02-02
CY2022Q1 us-gaap Dividend Payable Date To Be Paid Day Month And Year
DividendPayableDateToBePaidDayMonthAndYear
2022-02-16
CY2022Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.07
CY2022Q1 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
2966
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
1525596 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
1000167 usd
us-gaap Net Income Loss
NetIncomeLoss
2913086 usd
us-gaap Net Income Loss
NetIncomeLoss
5676773 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9369923
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9227912
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9355776
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9216216
CY2023Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
258146
CY2022Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
350885
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
346834
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
466430
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9628069
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9578797
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9702610
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9682646
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.16
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.11
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.31
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.62
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.16
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.11
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.30
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.59
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1544727
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
10.23
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
277613
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
11.41
ntic Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Including Cashless Exercises
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodIncludingCashlessExercises
178331
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
6.03
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1644009
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
10.88
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1166772
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
10.51
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.87
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
7.29
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y1M28D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y7D
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
339423 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
998311 usd
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
232883 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
698649 usd
CY2023Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
1366860 usd
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y6M
CY2023Q2 us-gaap Revenues
Revenues
20969726 usd
CY2022Q2 us-gaap Revenues
Revenues
18964921 usd
us-gaap Revenues
Revenues
59193317 usd
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
13280584 usd
CY2022Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
12722833 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
38747865 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
36977620 usd
CY2023Q2 us-gaap Revenues
Revenues
20969726 usd
CY2022Q2 us-gaap Revenues
Revenues
18964921 usd
us-gaap Revenues
Revenues
59193317 usd
us-gaap Revenues
Revenues
53906973 usd
CY2023Q2 ntic Total Fees For Services Provided To Joint Ventures Geographic Location
TotalFeesForServicesProvidedToJointVenturesGeographicLocation
1361311 usd
CY2023Q2 ntic Entity Wide Fees For Services Provided To Joint Ventures Geographic Percentage
EntityWideFeesForServicesProvidedToJointVenturesGeographicPercentage
1.000 pure
CY2022Q2 ntic Total Fees For Services Provided To Joint Ventures Geographic Location
TotalFeesForServicesProvidedToJointVenturesGeographicLocation
1329988 usd
CY2022Q2 ntic Entity Wide Fees For Services Provided To Joint Ventures Geographic Percentage
EntityWideFeesForServicesProvidedToJointVenturesGeographicPercentage
1.000 pure
ntic Total Fees For Services Provided To Joint Ventures Geographic Location
TotalFeesForServicesProvidedToJointVenturesGeographicLocation
3795862 usd
ntic Entity Wide Fees For Services Provided To Joint Ventures Geographic Percentage
EntityWideFeesForServicesProvidedToJointVenturesGeographicPercentage
1.000 pure
ntic Total Fees For Services Provided To Joint Ventures Geographic Location
TotalFeesForServicesProvidedToJointVenturesGeographicLocation
3835755 usd
ntic Entity Wide Fees For Services Provided To Joint Ventures Geographic Percentage
EntityWideFeesForServicesProvidedToJointVenturesGeographicPercentage
1.000 pure
CY2023Q2 us-gaap Noncurrent Assets
NoncurrentAssets
13810930 usd
CY2022Q3 us-gaap Noncurrent Assets
NoncurrentAssets
12170493 usd
CY2023Q2 us-gaap Revenues
Revenues
20969726 usd
CY2022Q2 us-gaap Revenues
Revenues
18964921 usd
us-gaap Revenues
Revenues
59193317 usd
us-gaap Revenues
Revenues
53906973 usd
CY2023Q2 ntic Entity Wide Trade Joint Venture Receivables Two Joint Ventures Percentage
EntityWideTradeJointVentureReceivablesTwoJointVenturesPercentage
0.651 pure
CY2022Q2 ntic Entity Wide Trade Joint Venture Receivables One Joint Venture
EntityWideTradeJointVentureReceivablesOneJointVenture
0.623 pure
CY2023Q2 us-gaap Interest Paid Net
InterestPaidNet
136168 usd
CY2022Q2 us-gaap Interest Paid Net
InterestPaidNet
23784 usd
us-gaap Interest Paid Net
InterestPaidNet
342643 usd
us-gaap Interest Paid Net
InterestPaidNet
34079 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
542295 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
834823 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
604314 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1260437 usd

Files In Submission

Name View Source Status
0001171843-23-004473-index-headers.html Edgar Link pending
0001171843-23-004473-index.html Edgar Link pending
0001171843-23-004473.txt Edgar Link pending
0001171843-23-004473-xbrl.zip Edgar Link pending
ex_541098.htm Edgar Link pending
ex_541099.htm Edgar Link pending
ex_541100.htm Edgar Link pending
ex_541101.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
ntic-20230531.xsd Edgar Link pending
ntic20230531_10q.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
ntic-20230531_cal.xml Edgar Link unprocessable
ntic-20230531_def.xml Edgar Link unprocessable
ntic-20230531_pre.xml Edgar Link unprocessable
ntic20230531_10q_htm.xml Edgar Link completed
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ntic-20230531_lab.xml Edgar Link unprocessable